Home.forex news reportVertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? I'm Not Convinced

Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? I'm Not Convinced

September 5, 2024

[ad_1]

Investment Overview
Vertex Pharmaceuticals (NASDAQ:VRTX), the Boston based Pharma giant with an almost monopolistic share of the Cystic Fibrosis treatment market, announced its Q2 2024 earnings at the beginning of August.
Product revenues were $2.65bn – up 6% year-on-year. GAAP R&D and SG&A…

[ad_2]

Source link

European Gas Approaches Oversold Zone After Three-Day Selloff

Rithm Capital's Updated Sector Comparative Analysis – Part 1 (Includes Recommendation For 19 Peers As Of 9/2/2024)

Forex News Report https://www.forexnewsreport.com

Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? I'm Not Convinced

LEAVE A REPLY Cancel reply

LATEST POSTS

Trade ideas thread – Wednesday, 11 September, insightful charts, technical analysis, ideas

ICYMI – Bank of Japan officials see little need to raise the benchmark rate at Sep meeting

Paul Marshall bolsters media baron credentials with £100mn Spectator purchase

This London Man's £2.6M Crypto ATM Scheme Just Blew Up in His Face

Most Popular

Trade ideas thread – Wednesday, 11 September, insightful charts, technical analysis, ideas

ICYMI – Bank of Japan officials see little need to raise the benchmark rate at Sep meeting

Paul Marshall bolsters media baron credentials with £100mn Spectator purchase

This London Man's £2.6M Crypto ATM Scheme Just Blew Up in His Face

Oil – private survey of inventory shows a headline crude oil draw vs. build expected

Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? I'm Not Convinced

LEAVE A REPLY Cancel reply

LATEST POSTS

Follow us

Most Popular